Lung cancer is one of the diseases that are affecting many people in the world today. One of the symptoms of this disease can be found in a person’s coughing behavior.
Prevention is better than the cure, and if treatment is to be successful, then spotting the early symptoms is important. Express reports that a symptom of lung cancer is coughing up blood, or phlegm with blood. Other symptoms of the disease include a persistent cough, an unusual change in coughing after a long time, chest or shoulder pain, fatigue, weight loss, loss of appetite, and shortness of breath.
Another symptom of lung cancer is a chest infection that seems to persist, or suffering from lung infections like bronchitis. These symptoms do not usually make themselves known until later on. Unfortunately, later on, when these symptoms do appear, it would mean that the cancer has already progressed or spread. Muscle wasting, as well as facial swelling and finger clubbing, are other, less common symptoms of the disease but are just as concerning.
It is important to keep in mind that experiencing one of these symptoms could be attributed to other conditions and not necessarily lung cancer. This is why consulting a doctor is important to get a proper diagnosis and treatment.
There is no definite cause for lung cancer as there are many factors that could contribute to a person getting a high or low risk of developing the disease. Heavy smokers, or smokers in general, have a high risk of developing lung cancer and a big portion of lung cancer patients are smokers. Those who are constantly exposed to pollution or carcinogenic substances like radon and asbestos are also at risk of the disease.
Non-smokers are not immune to lung cancer, as the secondhand smoke that they may inhale can also put them at risk. Other factors that would increase or give a person a low risk of developing lung cancer are family history - if any family members have had lung cancer or have died of lung cancer. Having a history of suffering from respiratory diseases can also put a person at risk.


Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 



